A Study to Evaluate the Efficacy and Safety of CT041 After Adjuvant Chemotherapy for Pancreatic Cancer
Clinical trial NCT05911217 · RECRUITING
Trial details
- NCT number
- NCT05911217
- Sponsor
- CARsgen Therapeutics Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-11
- Primary completion
- 2026-12-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.